Institut Pasteur sequences genome of the Zika virus
25 January 2016 | By Victoria White
The Zika virus is responsible for an unprecedented epidemic currently sweeping through the tropical regions of the Americas...
List view / Grid view
News
Apollo Therapeutics Fund launched to drive therapeutic innovation
25 January 2016 | By Victoria White
The Apollo Therapeutics Fund will support the translation of ground-breaking academic science into innovative new medicines for a broad range of diseases...
Domainex and Cresset form drug discovery services alliance
25 January 2016 | By Victoria White
The alliance will give clients access to the expertise of Domainex in protein expression, biochemical assays, hit identification, computational and medicinal chemistry; and to Cresset’s approach to hit identification and drug design...
Researchers isolate antibodies that neutralise multiple species of Ebola
22 January 2016 | By Victoria White
Researchers used a high-efficiency method they developed to quickly isolate and generate large quantities of monoclonal human antibodies from the blood of survivors of a 2007 outbreak in Uganda who were infected by the Bundibugyo Ebola virus...
New biomarkers may influence cancer drug design
22 January 2016 | By Victoria White
The research from Georgia State University scientists provides strong translational potential with respect to biomarkers that play critical roles in the development of endometrial/lung tumours...
Scientists discover method to potentially repair injured nerve cells
22 January 2016 | By Victoria White
Dartmouth researchers have discovered that one of their recently discovered chemical reactions is capable of delivering some of the most potent and rare neurotrophins...
Neurodegenerative diseases: The potential of cyclophilin inhibition
21 January 2016 | By Hans Fliri PhD, Chairman, Cypralis
Here, Dr Hans Fliri, Chairman and CEO of Selcia and Chairman of Cypralis, presents a strong case for targeting mitochondrial cyclophilin D to prevent progression of chronic neurodegenerative diseases...
Asterias transfers AST-VAC2 manufacturing processes to Cancer Research UK
21 January 2016 | By Victoria White
AST-VAC2 is an innovative immunotherapy product that contains mature dendritic cells derived from pluripotent stem cells...
MRCT and the Alzheimer’s Association team up to translate research into treatments
21 January 2016 | By Victoria White
MRCT will identify projects with the greatest promise for advancement as investigational therapies and advise the Alzheimer's Association on strategies for moving them forward such that they realise the maximum potential...
LDC enters new drug discovery partnership with Roche
21 January 2016 | By Victoria White
The Lead Discovery Centre (LDC) and Roche have announced that they are to collaborate to identify and leverage innovative therapeutic opportunities that address diseases of unmet medical need...
UC Berkeley researchers improve CRISPR-Cas9 gene editing technology
21 January 2016 | By Victoria White
The researchers have announced a major improvement in CRISPR-Cas9 technology that achieves an unprecedented success rate of 60% when replacing a short stretch of DNA with another...
PDi launched to enhance translation of phenotypic biology to novel therapeutics
20 January 2016 | By Victoria White
Through the Phenotypic Discovery Initiative (PDi), partners will build robust, disease-relevant phenotypic assays with a focus on human-derived systems with the aim of identifying new drug targets and hit molecules.
Microptosis could present an antimicrobial drug development opportunity
20 January 2016 | By Victoria White
Researchers have described a novel pathway called microptosis where the immune system's killer cells deliver a 3-phase knockout punch that kills intracellular parasites...
Researchers freeze EBV by disrupting the cell supply chain
20 January 2016 | By Victoria White
Researchers made B-cells sense they were starving by using the drug Rapamycin, enabling them to turn the senescence of EBV-infected cells on and off...
Regen BioPharma and NCATS to research the NR2F6 protein
20 January 2016 | By Victoria White
The collaboration will focus on identifying ligands for NR2F6 using Regen's screening methodology and the expertise and unique chemical libraries of NCATS...
